Hayato Fukuda

Resolvin E1/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23

Satoshi Deyama, Kento Shimoda, Hiroe Suzuki et al. · Psychopharmacology · 2017 · 75 citations

Biochemistry, Functional Selectivity, Medicine +4

Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS

Ai Sasaki, Hayato Fukuda, Narumi Shiida et al. · Analytical and Bioanalytical Chemistry · 2015 · 57 citations

Human Urine Samples, Biochemistry, Medicine +13

Identification of a Potent and Selective GPR4 Antagonist as a Drug Lead for the Treatment of Myocardial Infarction

Hayato Fukuda, Saki Ito, Kenji Watari et al. · ACS Medicinal Chemistry Letters · 2016 · 57 citations · Full text

Heart Failure, Drug Lead, Pharmacotherapy +16

Resolvin E3 attenuates lipopolysaccharide-induced depression-like behavior in mice

Satoshi Deyama, Kento Shimoda, Hiroyuki Ikeda et al. · Journal of Pharmacological Sciences · 2018 · 45 citations · Full text

Locomotor Activity, Pharmacotherapy, Experimental Pharmacology +17

Palladium-Nanoparticle-Catalyzed 1,7-Palladium Migration Involving C–H Activation, Followed by Intramolecular Amination: Regioselective Synthesis of <i>N</i>1-Arylbenzotriazoles and an Evaluation of Their Inhibitory Activity toward Indoleamine 2,3-Dioxygenase

Koji Takagi, Mohammad Al‐Amin, Naoyuki Hoshiya et al. · The Journal of Organic Chemistry · 2014 · 43 citations · Full text